253 related articles for article (PubMed ID: 4994883)
21. Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J
Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
[No Abstract] [Full Text] [Related]
22. [Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].
Barbu Z; Alexa M; Josefovics F
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):153-9. PubMed ID: 212812
[No Abstract] [Full Text] [Related]
23. The Australian rifampicin trial.
Proust A; Evans C
Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
[No Abstract] [Full Text] [Related]
24. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
Golanov VS; Bogdalova VE; Andreev LP; Losin EI; Ushakova AG; Meshcheriakov VG; Bondin SV
Probl Tuberk; 1991; (12):27-8. PubMed ID: 1803368
[TBL] [Abstract][Full Text] [Related]
25. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
Khomenko AG; Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE
Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
[No Abstract] [Full Text] [Related]
26. [Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
Kekkaku; 1973 Jan; 48(1):29-33. PubMed ID: 4632268
[No Abstract] [Full Text] [Related]
27. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
Kraan JK; Mulder RJ; van Dijk B
Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104
[No Abstract] [Full Text] [Related]
28. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Freerksen E
Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
[No Abstract] [Full Text] [Related]
29. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
30. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
Shukiurov ShZ
Probl Tuberk; 1973; 51(12):40-3. PubMed ID: 4782102
[No Abstract] [Full Text] [Related]
31. Tuberculosis in Acukland.
Swinburn PD
N Z Med J; 1973 Dec; 78(505):520-5. PubMed ID: 4205888
[No Abstract] [Full Text] [Related]
32. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
Grumbach F; Canetti G; Le Lirzin M
Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
[No Abstract] [Full Text] [Related]
33. [Bacteriologic test during rifampicin treatment].
Ivaldy F
Rev Tuberc Pneumol (Paris); 1969; 33(6):818-20. PubMed ID: 4989191
[No Abstract] [Full Text] [Related]
34. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
Kozulicyna TI; Korotajev GA
G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
[No Abstract] [Full Text] [Related]
35. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
Adamovich VN; Kolomytseva OS; Gur'ian IE
Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
[No Abstract] [Full Text] [Related]
36. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
Nitti V
Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
[No Abstract] [Full Text] [Related]
37. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
38. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
Kuz'min AV; Vasil'eva IA; Chernousova LN
Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
[TBL] [Abstract][Full Text] [Related]
39. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
Kohno S; Koga H; Kaku M; Maesaki S; Hara K
Chest; 1992 Dec; 102(6):1815-8. PubMed ID: 1446494
[TBL] [Abstract][Full Text] [Related]
40. A comparative trial with combinations of rifampicin, ethambutol and isoniazid (Hydronsan) in previously untreated cases of pulmonary tuberculosis.
Dormer BA; Salinger PL
S Afr Med J; 1971 Jun; 45(25):697-9. PubMed ID: 5559403
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
